A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer
Status:
Completed
Trial end date:
2018-12-18
Target enrollment:
Participant gender:
Summary
This research is being done to see if an investigational prostate cancer vaccine, called
GVAX, can safely be given together with a single intravenous injection of a drug called
cyclophosphamide to men that will undergo surgery to remove their cancerous prostate glands
who have also received standard hormonal therapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators:
BioSante Pharmaceuticals David H. Koch Charitable Foundation